The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 15 - 2024 |
doi: 10.3389/fphar.2024.1455425
This article is part of the Research Topic Immunomodulatory Natural Products - their Pharmacological and Therapeutic potential View all 7 articles
Investigating Anti-Urolithiatic Lead Compounds from Moringa oleifera Seeds
Provisionally accepted- 1 Islamia University of Bahawalpur, Bahawalpur, Pakistan
- 2 King Saud University, Riyadh, Riyadh, Saudi Arabia
- 3 Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences (CAS), Ürümqi, Xinjiang Uyghur Region, China
- 4 University of Agriculture, Faisalabad, Faisalabad, Punjab, Pakistan
- 5 Universiti Teknologi MARA Puncak Alam, Selangor, Selangor, Malaysia
Ethnopharmacological relevance: Moringa oleifera is a fast-growing tree, rich in secondary metabolites, and grows in tropical and sub-tropical areas of the world. It is reported to treat more than 300 diseases including urolithiasis. Kidney stone formation occurs in about 12% of the population worldwide. Crude extracts of different parts of M. oleifera are reported to possess antiurolithiatic potential.Objective: Since crude extracts of different parts of M. oleifera are reported to treat urolithiasis, it was aimed to explore phytochemicals responsible for antiurolithiatic potential present in the seeds.In this work, hydro-methanolic seeds' extract was fractionated with non-polar to polar solvents using petroleum ether, dichloromethane, ethylacetate, methanol and finally water. Thin layer chromatography of fractions led to the combination and chromatograph the dichloromethane and ethylacetate fractions over silica that furnished the isolation of two compounds that were characterized through FTIR, 1 HNMR, and 13 CNMR. Furthermore, these compounds were subjected to the determination of antiurolithiatic potential both in vivo and in vitro fashion.Cystone, a herbal medicine, was used as a standard drug in in vivo studies.Results: FTIR and 1 HNMR spectroscopic data helped to elucidate the compound as Niazimicin, a thiocarbamato aromatic rhamnoside, while the second compound was characterized as thiocarbamato aromatic glucoside. In vivo results indicated that niazimicin showed significant results against urolithiasis as compared to the standard, cystone, while in vitro studies of both of the compounds showed good activity against kidney stone formation.The current research work shows that Moringa oleifera seeds contain secondary metabolites, consisting of thiocarbamates moiety, which are potent antiurolithiatic compounds as compared to cystone, the standard drug.
Keywords: Moringa oleifera, Medicinal value, Niazimicin, Kidney stone, Cystone, Urolithiasis, Thiocarbamates
Received: 26 Jun 2024; Accepted: 19 Dec 2024.
Copyright: © 2024 Raza, Ali, Soufan, Anjum, Jabeen, NAZIM, Ashraf, Hussain, Nadeem, Shah, Ihsan and Abdullah. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hina Ali, Islamia University of Bahawalpur, Bahawalpur, Pakistan
Walid Soufan, King Saud University, Riyadh, 11451, Riyadh, Saudi Arabia
Shazia Anjum, Islamia University of Bahawalpur, Bahawalpur, Pakistan
Qaiser Jabeen, Islamia University of Bahawalpur, Bahawalpur, Pakistan
Safdar Hussain, Islamia University of Bahawalpur, Bahawalpur, Pakistan
Raziya Nadeem, University of Agriculture, Faisalabad, Faisalabad, 38000, Punjab, Pakistan
Muhammad Zahid Ihsan, Islamia University of Bahawalpur, Bahawalpur, Pakistan
Muhammad Abdullah, Islamia University of Bahawalpur, Bahawalpur, Pakistan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.